The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma

DNA and Cell Biology

Volumn 32, Issue 10, 2013, Pages 594-600

  Fan, Yu ^a   Zhang, Xu ^a   Yang, Zhi Hui ^a   Sun, Xing Wang ^a   Li, Shi Ning ^a   Zhong, Li ^a   Cheng, Xu ^b   Wang, Yu ^c   Ma, Yue Rong ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b Fourth People's Hospital of Zigong City   (China)

^c People's Hospital of Jianyang City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; OSTEOPONTIN; TUMOR MARKER;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84884757559     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2090     Document Type: Article

References (35)

1. Agrawal, D., et al. (.2002). Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94, 513-521
2. Barizzone, N., et al. (.2011). Association of osteopontin regulatory polymorphisms with systemic sclerosis. Hum Immunol 72, 930-934
3. Bhattacharya, S.D., et al. (.2010). Micro-RNA-181a regulates osteopontin- dependent metastatic function in hepatocellular cancer cell lines. Surgery 148, 291-297
4. Chin, L.J., et al. (.2008). A SNP in a let-7 microRNA complementary site in the KRAS 3¢ untranslated region increases nonsmall cell lung cancer risk. Cancer Res 68, 8535-8540
5. Chiu, Y.W., et al. (.2010). The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol 46, 302-306
6. Conne, B., et al. (.2000). The 3¢ untranslated region of messenger RNA: A molecular ''hotspot'' for pathology? Nat Med 6, 637-641
7. D'Alfonso, S., et al. (.2005). Two single-nucleotide polymorphisms in the 5¢ and 3¢ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 52, 539-547
8. Denhardt, D.T., et al. (.1995). Osteopontin-induced modifications of cellular functions. Ann N Y Acad Sci 760, 127-142
9. Dong, Q.Z., et al. (.2013). Osteopontin promoter polymorphisms at locus - 443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology 57, 1024-1034
10. El-Tanani, M.K., et al. (.2006). The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 17, 463-474
11. Fedarko, N.S., et al. (.2001). Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7, 4060-4066
12. Fritz, A.G. (.2000). International Classification of Diseases for Oncology, 3rd edition (World Health Organization
13. Giacopelli, F., et al. (.2004). Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 20, 87-96
14. Glas, J., et al. (.2011). The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PLoS One 6, e29309
15. Goparaju, C.M., et al. (.2010). Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. J Thorac Oncol 5, 1516-1523
16. Han, S., et al. (.2008). Osteopontin and systemic lupus erythematosus association: A probable gene-gender interaction. PLoS One 3, e0001757
17. Huang, J., et al. (.2012). Osteopontin-enhanced hepatic metastasis of colorectal cancer cells. PLoS One 7, e47901
18. Jemal, A., et al. (.2011). Global cancer statistics. CA Cancer J Clin 61, 69-90
19. Landi, D., et al. (.2008). Polymorphisms within micro-RNAbinding sites and risk of sporadic colorectal cancer. Carcinogenesis 29, 579-584
20. Liu, Y.L., et al. (.2011). Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer. Hepatogastroenterology 58, 383-387
21. Lumachi, F., et al. (.2012). Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. Anticancer Res 32, 985-988
22. McAllister, S.S., et al. (.2008). Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133, 994-1005
23. Notarnicola, M., et al. (.2005). Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology 68, 371-374
24. Poruk, K.E., et al. (.2013). Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas 42, 193-197
25. Rao, G., et al. (.2013). Reciprocal interactions between tumorassociated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res 19, 785-797
26. Shimada, Y., et al. (.2005). Clinical significance of osteopontin in esophageal squamous cell carcinoma: Comparison with common tumor markers. Oncology 68, 285-292
27. Sobin, L.H., et al. (.2009). TNM Classification of Malignant Tumors, 7th edition (Wiley-Blackwell
28. Sodek, J., et al. (.2000). Osteopontin. Crit Rev Oral Biol Med 11, 279-303
29. Trivedi, T., et al. (.2011). Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. Biomed Biotechnol 2011, 802581
30. Wang, K.X., et al. (.2008). Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev 19, 333-345
31. Weber, G.F., et al. (.1997). Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 109, 1-9
32. Wild, N., et al. (.2010). A combination of serum markers for the early detection of colorectal cancer. Clin Cancer Res 16, 6111-6121
33. Xu, Q., et al. (.2011). OPN gene polymorphisms are associated with susceptibility and clinicopatholigical characteristics of cervical cancer in a Chinese cohort. Cancer Biomark 10, 233-239
34. Zhao, F., et al. (.2012). Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer. BMC Cancer 12, 477
35. Zheng, S. (.2006). The Basic Reserch and Practice to Colorectal Cancer. General Peoples Publishing Press: 2-4